Business · 1 sources covering this

Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute

The Delhi High Court allowed Zydus Lifesciences to continue manufacturing Ikra but temporarily barred supplies after AbbVie alleged patent infringement.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute
The Delhi High Court allowed Zydus Lifesciences to continue manufacturing Ikra but temporarily barred supplies after AbbVie alleged patent infringement.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/1179b6770ee10cf84098ee1122710417ecd03389"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute"></iframe>

Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute

How 1 sources are covering this

Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute

More from Business

UK to ban Iran's Islamic Revolutionary Guard Corps, supporters will face 14 years in jail

HCLTech Q1 Attrition Rate Rises To 12.7%, Headcount Falls By Over 3,000

HCLTech Declares Dividend Of Rs 12 Per Share As Q1 Profit Climbs; Check Record Date

Louvre heist: Mastermind ‘wasn't happy’; thought burglars ‘could have taken more’

Reader

Trust & legal

Across the network